Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-21
DOI
10.1038/s41598-019-48634-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients
- (2018) E. Palmerini et al. ACTA ONCOLOGICA
- Rhabdomyosarcoma, Ewing Sarcoma, and Other Round Cell Sarcomas
- (2018) Alberto S. Pappo et al. JOURNAL OF CLINICAL ONCOLOGY
- Patient-derived xenograft models in musculoskeletal malignancies
- (2018) Wan Lu et al. Journal of Translational Medicine
- A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy
- (2018) Maria Cristina Manara et al. MOLECULAR CANCER THERAPEUTICS
- The Generation and Application of Patient-Derived Xenograft Model for Cancer Research
- (2018) Jaeyun Jung et al. Cancer Research and Treatment
- The mice with human tumours: Growing pains for a popular cancer model
- (2018) Cassandra Willyard NATURE
- Survival after second and subsequent recurrences in osteosarcoma: a retrospective multicenter analysis
- (2018) Elisa Tirtei et al. TUMORI
- Bortezomib sensitizes human osteosarcoma cells to adriamycin-induced apoptosis through ROS-dependent activation of p-eIF2α/ATF4/CHOP axis
- (2017) Miao Xian et al. INTERNATIONAL JOURNAL OF CANCER
- Genome-wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcoma
- (2017) Jan Smida et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer: A precision approach to tumour treatment
- (2017) Rodrigo Dienstmann et al. NATURE
- Orthotopic patient-derived xenografts of paediatric solid tumours
- (2017) Elizabeth Stewart et al. NATURE
- Patient-derived xenografts undergo mouse-specific tumor evolution
- (2017) Uri Ben-David et al. NATURE GENETICS
- Children first
- (2017) NATURE MEDICINE
- Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000–2016
- (2017) Grégoire Fourcade et al. PLoS One
- The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities
- (2016) Elizabeth Stewart et al. DEVELOPMENTAL BIOLOGY
- Patient-derived xenografts: a relevant preclinical model for drug development
- (2016) Luca Pompili et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- US cancer institute to overhaul tumour cell lines
- (2016) Heidi Ledford NATURE
- BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models
- (2016) Srikanth R. Ambati et al. Oncotarget
- Editorial: Biology-Driven Targeted Therapy of Pediatric Soft-Tissue and Bone Tumors: Current Opportunities and Future Challenges
- (2016) Thomas G. P. Grünewald et al. Frontiers in Oncology
- Process development of a human recombinant diabody expressed in E. coli: engagement of CD99-induced apoptosis for target therapy in Ewing’s sarcoma
- (2015) Diego Moricoli et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Advances in emerging drugs for osteosarcoma
- (2015) Claudia Maria Hattinger et al. EXPERT OPINION ON EMERGING DRUGS
- Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies
- (2015) Jeroen Depreeuw et al. GYNECOLOGIC ONCOLOGY
- Ewing Sarcoma: Current Management and Future Approaches Through Collaboration
- (2015) Nathalie Gaspar et al. JOURNAL OF CLINICAL ONCOLOGY
- Establishment of a patient-derived orthotopic osteosarcoma mouse model
- (2015) Claudia Blattmann et al. Journal of Translational Medicine
- The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
- (2015) José Luis Ordóñez et al. Oncotarget
- Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors
- (2015) Gennadiy Bondarenko et al. NEOPLASIA
- Patient-derived xenografts for individualized care in advanced sarcoma
- (2014) Justin Stebbing et al. CANCER
- Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
- (2014) F. Ricci et al. CANCER RESEARCH
- CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin
- (2014) C. Guerzoni et al. CLINICAL CANCER RESEARCH
- Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts
- (2014) Monique D. Topp et al. Molecular Oncology
- Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations
- (2014) F. Tirode et al. Cancer Discovery
- Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
- (2014) M. Hidalgo et al. Cancer Discovery
- Targeting the DNA Repair Pathway in Ewing Sarcoma
- (2014) Elizabeth Stewart et al. Cell Reports
- A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
- (2013) X. Zhang et al. CANCER RESEARCH
- Patient-Derived Tumor Xenografts: Transforming Clinical Samples into Mouse Models
- (2013) D. Siolas et al. CANCER RESEARCH
- Generation of Human Single-chain Antibody to the CD99 Cell Surface Determinant Specifically Recognizing Ewing’s Sarcoma Tumor Cells
- (2013) Mara Gellini et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies
- (2013) Xu-chao Zhang et al. Journal of Translational Medicine
- Patient-derived xenografts, the cancer stem cell paradigm and cancer pathobiology in the 21st century
- (2013) Samuel A Williams et al. LABORATORY INVESTIGATION
- Antitumor effects of a novel histone deacetylase inhibitor NK-HDAC-1 on breast cancer
- (2013) ZHONG-HUA LI et al. ONCOLOGY REPORTS
- Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer
- (2012) S. Julien et al. CLINICAL CANCER RESEARCH
- Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue
- (2012) David J Monsma et al. Journal of Translational Medicine
- Common Musculoskeletal Tumors of Childhood and Adolescence
- (2012) Carola A.S. Arndt et al. MAYO CLINIC PROCEEDINGS
- Human Solid Tumor Xenografts in Immunodeficient Mice Are Vulnerable to Lymphomagenesis Associated with Epstein-Barr Virus
- (2012) Kui Chen et al. PLoS One
- Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
- (2011) J.-P. Gillet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Molecularly Annotated Platform of Patient-Derived Xenografts ("Xenopatients") Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
- (2011) A. Bertotti et al. Cancer Discovery
- Survival in high-grade osteosarcoma: improvement over 21 years at a single institution
- (2009) P. Picci et al. ANNALS OF ONCOLOGY
- Advances in Ewing's Sarcoma Research: Where Are We Now and What Lies Ahead?
- (2009) J. L. Ordonez et al. CANCER RESEARCH
- A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro
- (2009) V. C. Daniel et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started